176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
846.15%
Net income growth above 1.5x TSM's 15.89%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.04%
Negative yoy D&A while TSM is 1.80%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
13.51%
Deferred tax of 13.51% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
8.33%
SBC growth of 8.33% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-270.00%
Both reduce yoy usage, with TSM at -55.80%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
62.71%
AR growth while TSM is negative at -16.68%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
666.67%
Inventory growth well above TSM's 297.02%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-62.96%
Both negative yoy AP, with TSM at -31.41%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-409.38%
Both reduce yoy usage, with TSM at -259.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-65.12%
Negative yoy while TSM is 34.31%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
56.44%
Operating cash flow growth above 1.5x TSM's 18.50%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
29.17%
Some CapEx rise while TSM is negative at -39.66%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Negative yoy acquisition while TSM stands at 54.60%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-36.03%
Negative yoy purchasing while TSM stands at 16.29%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-25.98%
We reduce yoy sales while TSM is 124.69%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-79.17%
We reduce yoy other investing while TSM is 225.42%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-180.57%
Both yoy lines negative, with TSM at -12.86%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while TSM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.